glp-1 agonists names Receptor Agonists: Mascots & Mnemonics Patents and regulatory exclusivities on
Description
Understanding semaglutide expiration and stability prevents using degraded medication that may produce suboptimal results
Wharton S, Lingvay I, Bogdanski P, et al
10.2337/diacare.27.8.1915 51 HarkavyiA.AbuirmeilehA.LeverR.KingsburyA
17 Periods of protection from patents and exclusivities overlap, and both can block the FDA from approving generic versions of brand-name products
doi: 10.1080/13543776.2023.2274905
The review provides a comprehensive overview of an emerging therapeutic avenue for this challenging condition
